Inventor
KANDIMALLA EKAMBAR
US30 patents
⚠️ This page may combine multiple inventors who share the name “KANDIMALLA EKAMBAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDERA PHARMACEUTICALS INC
13 patentsUS7427405B2Sep 23, 2008
Immunostimulatory oligonucleotide multimers
IDERA PHARMACEUTICALS INC40 citations96
US7632822B2Dec 15, 2009
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
IDERA PHARMACEUTICALS INC17 citations93
US7566702B2Jul 28, 2009
Immunostimulatory oligonucleotide multimers
IDERA PHARMACEUTICALS INC28 citations93
US7498425B2Mar 3, 2009
Immunostimulatory oligonucleotide multimers
IDERA PHARMACEUTICALS INC28 citations93
US7498426B2Mar 3, 2009
Immunostimulatory oligonucleotide multimers
IDERA PHARMACEUTICALS INC28 citations93
US7470674B2Dec 30, 2008
Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
IDERA PHARMACEUTICALS INC48 citations93
US7405285B2Jul 29, 2008
Immunostimulatory oligonucleotide multimers
IDERA PHARMACEUTICALS INC35 citations93
US7115579B2Oct 3, 2006
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
IDERA PHARMACEUTICALS INC38 citations93
US7960362B2Jun 14, 2011
Synthetic agonists of TLR9
IDERA PHARMACEUTICALS INC19 citations92
US8383598B2Feb 26, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC12 citations84
US7884197B2Feb 8, 2011
Synthetic agonists of TLR9
IDERA PHARMACEUTICALS INC13 citations84
US7863250B2Jan 4, 2011
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
IDERA PHARMACEUTICALS INC9 citations84
US7776834B2Aug 17, 2010
Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
IDERA PHARMACEUTICALS INC12 citations84
KANDIMALLA EKAMBAR
7 patentsUS8426375B2Apr 23, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
KANDIMALLA EKAMBAR25 citations92
US8853375B2Oct 7, 2014
Toll like receptor modulators
KANDIMALLA EKAMBAR17 citations83
US8399423B2Mar 19, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
KANDIMALLA EKAMBAR12 citations83
US8188261B2May 29, 2012
Stabilized immune modulatory RNA (SIMRA) compounds
KANDIMALLA EKAMBAR13 citations83
US8153777B2Apr 10, 2012
Modulation of toll-like receptor 5 expression by antisense oligonucleotides
KANDIMALLA EKAMBAR3 citations62
US8153605B2Apr 10, 2012
Modulation of toll-like receptor 3 expression by antisense oligonucleotides
KANDIMALLA EKAMBAR0 citations51
US8492358B2Jul 23, 2013
Agonists of toll-like receptor 3 and methods of their use
KANDIMALLA EKAMBAR1 citations47
AGRAWAL SUDHIR
3 patentsUS8431544B1Apr 30, 2013
Compositions for inhibiting gene expression and uses thereof
AGRAWAL SUDHIR48 citations93
US8420615B2Apr 16, 2013
Immunostimulatory oligonucleotide multimers
AGRAWAL SUDHIR3 citations62
US8877722B2Nov 4, 2014
Compositions for inhibiting gene expression and uses thereof
AGRAWAL SUDHIR1 citations47
ZHU FU-GANG
2 patentsUS8987221B2Mar 24, 2015
Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (IRO) antagonists of TLR7 and TLR9
ZHU FU-GANG11 citations81
US8853177B2Oct 7, 2014
Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
ZHU FU-GANG6 citations81
EXICURE OPERATING COMPANY
2 patentsUS11866700B2Jan 9, 2024
Liposomal spherical nucleic acid (SNA) constructs presenting antisense oligonucleotides (ASO) for specific knockdown of interleukin 17 receptor mRNA
EXICURE OPERATING COMPANY0 citations56
US11696954B2Jul 11, 2023
Synthesis of spherical nucleic acids using lipophilic moieties
EXICURE OPERATING COMPANY0 citations44